These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 10782886)

  • 21. Estrogen receptor, progesterone receptor, and human epidermal growth factor receptor 2 expression in breast cancer FNA cell blocks and paired histologic specimens: A large retrospective study.
    Vohra P; Buelow B; Chen YY; Serrano M; Vohra MS; Berry A; Ljung BM
    Cancer Cytopathol; 2016 Nov; 124(11):828-835. PubMed ID: 27315045
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparing breast biomarker status between routine immunohistochemistry and FISH studies and Oncotype DX testing, a study of 610 cases.
    Neely C; You S; Mendoza PM; Aneja R; Sahin AA; Li X
    Breast J; 2018 Nov; 24(6):889-893. PubMed ID: 30230095
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Angiogenic effect of interleukin-8 in breast cancer and its association with estrogen receptor].
    Lin Y; Wang SM; Huang RP
    Zhonghua Yi Xue Za Zhi; 2005 Jun; 85(20):1419-23. PubMed ID: 16029657
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical significance of topoisomerase 2A expression and gene change in operable invasive breast cancer.
    Qiao JH; Jiao DC; Lu ZD; Yang S; Liu ZZ
    Tumour Biol; 2015 Sep; 36(9):6833-8. PubMed ID: 25846735
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Estrogen receptor gene amplification is found in some estrogen receptor-positive human breast tumors.
    Nembrot M; Quintana B; Mordoh J
    Biochem Biophys Res Commun; 1990 Jan; 166(2):601-7. PubMed ID: 2302226
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Demethylation of the estrogen receptor gene in estrogen receptor-negative breast cancer cells can reactivate estrogen receptor gene expression.
    Ferguson AT; Lapidus RG; Baylin SB; Davidson NE
    Cancer Res; 1995 Jun; 55(11):2279-83. PubMed ID: 7538900
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Fluorescence immunophenotyping and interphase cytogenetics as a tool for the investigation of cytogenetic aberrations of multiple myeloma].
    Wang XW; Li JY; Chen LJ; Qian SX; Hong M; Qiao C; Zhang JF; Xu W; Lu H
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Dec; 16(6):1316-9. PubMed ID: 19099635
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expression of sex steroid receptors and their co-factors in normal and malignant breast tissue: AIB1 is a carcinoma-specific co-activator.
    Hudelist G; Czerwenka K; Kubista E; Marton E; Pischinger K; Singer CF
    Breast Cancer Res Treat; 2003 Mar; 78(2):193-204. PubMed ID: 12725419
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Simultaneous fluorescence immunophenotyping and Her-2/neu genotyping (FICTION) in breast carcinoma candidates to target therapy.
    Gatta LB; Incardona P; Cadei M; Grigolato P; Simoncelli S; Balzarini P
    Appl Immunohistochem Mol Morphol; 2012 Jul; 20(4):413-20. PubMed ID: 22417857
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expression of a constitutively active estrogen receptor variant in the estrogen receptor-negative BT-20 human breast cancer cell line.
    Castles CG; Fuqua SA; Klotz DM; Hill SM
    Cancer Res; 1993 Dec; 53(24):5934-9. PubMed ID: 8261406
    [TBL] [Abstract][Full Text] [Related]  

  • 31. miR-191/DAB2 axis regulates the tumorigenicity of estrogen receptor-positive breast cancer.
    Tian X; Zhang Z
    IUBMB Life; 2018 Jan; 70(1):71-80. PubMed ID: 29247596
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Downregulation of estrogen receptor and modulation of growth of breast cancer cell lines mediated by paracrine stromal cell signals.
    Huang J; Woods P; Normolle D; Goff JP; Benos PV; Stehle CJ; Steinman RA
    Breast Cancer Res Treat; 2017 Jan; 161(2):229-243. PubMed ID: 27853906
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Distinct mechanisms of loss of estrogen receptor alpha gene expression in human breast cancer: methylation of the gene and alteration of trans-acting factors.
    Yoshida T; Eguchi H; Nakachi K; Tanimoto K; Higashi Y; Suemasu K; Iino Y; Morishita Y; Hayashi S
    Carcinogenesis; 2000 Dec; 21(12):2193-201. PubMed ID: 11133808
    [TBL] [Abstract][Full Text] [Related]  

  • 34. An integrated analysis of genes and pathways exhibiting metabolic differences between estrogen receptor positive breast cancer cells.
    Mandal S; Davie JR
    BMC Cancer; 2007 Sep; 7():181. PubMed ID: 17883861
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Functional repression of estrogen receptor a by arsenic trioxide in human breast cancer cells.
    Chen GC; Guan LS; Hu WL; Wang ZY
    Anticancer Res; 2002; 22(2A):633-8. PubMed ID: 12014631
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Correlation between erythropoietin receptor(s) and estrogen and progesterone receptor expression in different breast cancer cell lines.
    Trošt N; Hevir N; Rižner TL; Debeljak N
    Int J Mol Med; 2013 Mar; 31(3):717-25. PubMed ID: 23314808
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Transcriptional activation of functional endogenous estrogen receptor gene expression in MCF10AT cells: a model for early breast cancer.
    Shekhar PV; Chen ML; Werdell J; Heppner GH; Miller FR; Christman JK
    Int J Oncol; 1998 Nov; 13(5):907-15. PubMed ID: 9772278
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Regional cyclin D1 overexpression or hypoxia correlate inversely with heterogeneous oestrogen receptor-alpha expression in human breast cancer.
    Kronblad A; Helczynska K; Nielsen NH; Påhlman E; Emdin S; Påhlman S; Landberg G
    In Vivo; 2003; 17(4):311-8. PubMed ID: 12929585
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expression and regulation of retinoid-inducible gene 1 (RIG1) in breast cancer.
    Shyu RY; Chang SC; Yu JC; Hsu SJ; Chou JM; Lee MS; Jiang SY
    Anticancer Res; 2005; 25(3c):2453-60. PubMed ID: 16080475
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Molecular aspects of estrogen receptor variants in breast cancer.
    Fuqua SA; Wolf DM
    Breast Cancer Res Treat; 1995 Sep; 35(3):233-41. PubMed ID: 7579493
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.